Events
Sysnav Healthcare at WMS 2025
Sysnav Healthcare was delighted to participate in the 30th Annual International Congress of the World Muscle
October 17, 2025
At Sysnav Healthcare, we envision a future where clinical trials are guided by accurate, real-world measurements of patient function, enabling faster, more reliable, and meaningful evaluation of therapies. By integrating high-precision wearable technology with rigorous analytics, we aim to transform how disease progression and treatment efficacy are assessed.
Our mission is to provide robust, scientifically validated functional assessments that generate actionable real-world data. Through the Syde® platform, we capture precise measurements of patient mobility and motor function, enabling healthcare teams and researchers to make confident, regulatory-ready decisions.
At Sysnav Healthcare, we envision a future where clinical trials are guided by accurate, real-world measurements of patient function, enabling faster, more reliable, and meaningful evaluation of therapies. By integrating high-precision wearable technology with rigorous analytics, we aim to transform how disease progression and treatment efficacy are assessed.
Our mission is to provide robust, scientifically validated functional assessments that generate actionable real-world data. Through the Syde® platform, we capture precise measurements of patient mobility and motor function, enabling healthcare teams and researchers to make confident, regulatory-ready decisions.
Sysnav Healthcare is an active contributor to the development and adoption of digital endpoints in clinical research. Through collaborations with industry partners, academic institutions, and digital health communities, we help shape best practices, foster scientific innovation, and support the integration of these measures into clinical trials.
Sysnav Healthcare collaborates with premier academic institutions, including Harvard University, University of Oxford, and Stanford University, to advance the development and validation of digital endpoints across 20 disease indications.
Through a multi-year collaboration with Roche, Sysnav Healthcare is developing validated digital endpoints and next-generation wearable technologies to support clinical research and enhance patient outcomes in several mobility-affecting diseases.
Sysnav Healthcare actively collaborates with the Digital Medicine Society to advance standards and best practices for digital endpoints in clinical research.
Sysnav Healthcare contributed to the development of the Digital Medicine Society’s V3+ framework. V3+ incorporated usability validation to the original V3 framework for the verification and validation of digital health technologies.
By integrating ease of use, efficiency, and user satisfaction into the framework, we reinforced our commitment to patient-centricity in the adoption of digital endpoints.
Sysnav Healthcare contributed to DiMe’s initiative to provide guidance and resources to sponsors to help them assess the value and quantify ROI of digital endpoints.
To demonstrate this in practice, we authored a case study highlighting how the Syde platform generates high-quality real-world evidence while enhancing trial efficiency.
Sysnav Healthcare was created by the meeting of experts in neuromuscular diseases and advanced motion-capture solutions, who derived meaningful clinical applications from innovative technology. From the start, Sysnav Healthcare has been led by:
Sysnav Healthcare is always looking for new talents.
Sysnav Healthcare was delighted to participate in the 30th Annual International Congress of the World Muscle
Last week, Sysnav Healthcare participated in the 2025 Annual NEALS Meeting in Florida. In collaboration with
Digital endpoints, particularly those based on passive monitoring, enable the capture of meaningful, regulatory-relevant data from